6Pascuzzi RM. The history of myasthenia gravis [J]. Neurol Clin, 1994,12 (2) :231-242.
7Maggi L, Mantegazza R. Treatment of myasthenia gravis focus on pyri- dostlgmine [J]. Clin Drug Investig, 2011,31 ( 10 ) : 691-701.
8Mehndiratta MM ,Pandey S,Kuntzer T. Acetylcholinesterase inhibitor treatment for myasthenia gravis [J]. Cochrane Database Syst Rev, 2011, (2) :CD006986.
9Sieb JP, Kohler W. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis:resuhs of a prospective muhicenter open-label trial [J]. Clin Neurol Neurosurg,2010,112(9):781-784.
10Yu QS,Holloway HW,Luo W,et al. Long-acting anticholinesterases for myasthenia gravis:synthesis and activities of quaternary phenyl- carbamates of neostigmine,pyridostigmine and physostigmine [J]. Bioorg Med Chem, 2010,18 ( 13 ) :4687-4693.
